Clin2
NCT07248280Possibly a fitCompleted

Preventing nausea and vomiting after surgery in high-risk patients

Nausea and Vomiting, PostoperativePrevention

Treatments studied

Part of Digestive system clinical trials.

This trial tests if adding the drug Aprepitant to standard care helps prevent nausea and vomiting after surgery in people who are at high risk for these side effects. It might offer better relief for patients undergoing same-day surgery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
260 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are having surgery that doesn't require an overnight stay.
  • You are at high risk for nausea and vomiting after surgery (for example, if you are female, don't smoke, have had motion sickness or nausea after past surgeries, or expect strong pain medicine after surgery).
  • You are not allergic to Aprepitant (brand name Emend).
  • You are not taking certain other medicines like pimozide, terfenadine, astemizole, comtadin, or cisapride.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06357234Recruiting· Phase 2
Aprepitant to prevent nausea after child scoliosis surgery

This trial tests if a drug called Aprepitant, given before surgery, can better prevent nausea and vomiting after scoliosis repair in children. It is for children aged 8 to 18 who are having spinal fusion surgery for a certain type of scoliosis.

Halifax, Nova Scotia
NCT07631910Not yet recruiting
Preventing nausea after gynecological surgery

This trial tests a combination of methods to prevent nausea and vomiting after gynecological surgery using a laparoscope (a small camera). The study uses acupressure and other supportive care techniques to see if they can reduce post-surgery nausea, which is a common and uncomfortable side effect.

Hangzhou, Zhejiang
NCT07371728Not yet recruiting· Phase 4
Testing aprepitant for nausea after ear surgery

This study tests whether a medication called aprepitant can reduce nausea and vomiting after middle ear surgery. If you are having certain types of ear surgery under general anesthesia, you may be able to join.

Montreal, Quebec
NCT06543966Not yet recruiting· Phase 3
Aprepitant shot for preventing nausea after gynecologic or abdominal surgery

This trial tests an aprepitant injection to prevent nausea and vomiting after laparoscopic gynecologic or abdominal surgery lasting at least 1 hour. It may be an option for people who want to reduce post-operative sickness.

NCT07639723Not yet recruiting· Phase 4
Aprepitant to Help You Go Home the Same Day After Knee Surgery

This study tests whether a medication called aprepitant can help prevent nausea after total knee replacement (TKA) surgery, so you can safely go home the same day instead of staying overnight. Nausea is common after surgery and can delay discharge.

Skokie, Illinois
NCT06887621Recruiting· Phase 2
Adding oral amisulpride to prevent nausea after gynecologic surgery

This trial tests if adding a medication called amisulpride to standard anti-nausea drugs can better prevent vomiting and nausea after gynecologic surgery. It is for women at high risk of postoperative nausea.

São Paulo, São Paulo

Hear when a new Nausea and Vomiting, Postoperative trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.